SynKIR-110
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SynKIR-110, covering 2024-11-07 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma [Phase 1]